MiR-16-5p suppresses breast cancer proliferation by targeting ANLN

被引：0
|
作者：
Ziming Wang
Siyuan Hu
Xinyang Li
Zhiwei Liu
Danyang Han
Yukun Wang
Limin Wei
Guangping Zhang
Xinshuai Wang
机构：
[1] College of Clinical Medicine,Henan Key Laboratory of Cancer Epigenetics; Cancer hospital, The First Affiliated Hospital
[2] Medical College of Henan University of Science and Technology,undefined
[3] Zhoukou first people’s Hospital,undefined
来源：
BMC Cancer | / 21卷
关键词：
Breast cancer; Bioinformatics; ANLN; miR-16-5p; Proliferation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] MiR-16-5p suppresses breast cancer proliferation by targeting ANLN
    Wang, Ziming
    Hu, Siyuan
    Li, Xinyang
    Liu, Zhiwei
    Han, Danyang
    Wang, Yukun
    Wei, Limin
    Zhang, Guangping
    Wang, Xinshuai
    BMC CANCER, 2021, 21 (01)
  • [2] miR-16-5p inhibits chordoma cell proliferation, invasion and metastasis by targeting
    Zhang, Hongliang
    Yang, Kang
    Ren, Tingting
    Huang, Yi
    Tang, Xiaodong
    Guo, Wei
    CELL DEATH & DISEASE, 2018, 9
  • [3] miR-16-5p Suppresses Progression and Invasion of Osteosarcoma via Targeting at Smad3
    Gu, Zhijian
    Li, Zhikun
    Xu, Ruijun
    Zhu, Xiaodong
    Hu, Ruixi
    Xue, Yonghua
    Xu, Wei
    FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [4] Role of miR-16-5p in the proliferation and metastasis of hepatocellular carcinoma
    Cheng, B.
    Ding, F.
    Huang, C-Y
    Xia, H.
    Fei, F-Y
    Li, J.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2019, 23 (01) : 137 - 145
  • [5] miR-129-5p suppresses breast cancer proliferation by targeting CBX4
    Meng, R.
    Fang, J.
    Yu, Y.
    Hou, L. K.
    Chi, J. R.
    Chen, A. X.
    Zhao, Y.
    Cao, X. C.
    NEOPLASMA, 2018, 65 (04) : 572 - 578
  • [6] miR-16-5p inhibits chordoma cell proliferation, invasion and metastasis by targeting Smad3
    Hongliang Zhang
    Kang Yang
    Tingting Ren
    Yi Huang
    Xiaodong Tang
    Wei Guo
    Cell Death & Disease, 9
  • [7] MiR-16-5p regulates postmenopausal osteoporosis by directly targeting VEGFA
    Yu, Tao
    You, Xiaomeng
    Zhou, Haichao
    He, Wenbao
    Li, Zihua
    Li, Bing
    Xia, Jiang
    Zhu, Hui
    Zhao, Youguang
    Yu, Guangrong
    Xiong, Yuan
    Yang, Yunfeng
    AGING-US, 2020, 12 (10): : 9500 - 9514
  • [8] MiR-138-5p targeting LIMK1 suppresses breast cancer cell proliferation and motility
    Li, Dengfeng
    Song, Hongming
    Wu, Tianqi
    Xie, Dan
    Hu, Jiashu
    Zhao, Junyong
    Fang, Lin
    RSC ADVANCES, 2017, 7 (82) : 52030 - 52038
  • [9] The mechanism and therapeutic potential of lncRNA MIR497HG/miR-16-5p axis in breast cancer
    Cheng, Quan
    Yu, Dong-Yang
    Zhou, Yong-Hong
    Huang, Jian-Yuan
    BMC WOMENS HEALTH, 2024, 24 (01)
  • [10] MiR-16-5p suppresses myofibroblast activation in systemic sclerosis by inhibiting NOTCH signaling
    Yao, Qicen
    Xing, Yixi
    Wang, Zaiyan
    Liang, Jin
    Lin, Qianqi
    Huang, Meiqiong
    Chen, Yiling
    Lin, Bo
    Xu, Xiayu
    Chen, Weifei
    AGING-US, 2021, 13 (02): : 2640 - 2654
12345